Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Defining biomarkers in oral cancer according to smoking and drinking status.
Rochefort J, Karagiannidis I, Baillou C, Belin L, Guillot-Delost M, Macedo R, Le Moignic A, Mateo V, Soussan P, Brocheriou I, Teillaud JL, Dieu-Nosjean MC, Bertolus C, Lemoine FM, Lescaille G. Rochefort J, et al. Among authors: teillaud jl. Front Oncol. 2023 Jan 11;12:1068979. doi: 10.3389/fonc.2022.1068979. eCollection 2022. Front Oncol. 2023. PMID: 36713516 Free PMC article.
HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immunotherapy.
Bravo AI, Aris M, Panouillot M, Porto M, Dieu-Nosjean MC, Teillaud JL, Barrio MM, Mordoh J. Bravo AI, et al. Among authors: teillaud jl. Front Immunol. 2023 Aug 25;14:1231734. doi: 10.3389/fimmu.2023.1231734. eCollection 2023. Front Immunol. 2023. PMID: 37691949 Free PMC article.
Tertiary lymphoid structures in anticancer immunity.
Teillaud JL, Houel A, Panouillot M, Riffard C, Dieu-Nosjean MC. Teillaud JL, et al. Nat Rev Cancer. 2024 Sep;24(9):629-646. doi: 10.1038/s41568-024-00728-0. Epub 2024 Aug 8. Nat Rev Cancer. 2024. PMID: 39117919 Review.
Potent immunomodulatory and antitumor effect of anti-CD20-IL2no-alpha tri-functional immunocytokine for cancer therapy.
Casadesús AV, Cruz BM, Díaz W, González MÁ, Gómez T, Fernández B, González A, Ledón N, Sosa K, Castro K, López A, Plasencia C, Ramírez Y, Teillaud JL, Hernández C, León K, Hernández T. Casadesús AV, et al. Among authors: teillaud jl. Front Immunol. 2022 Dec 9;13:1021828. doi: 10.3389/fimmu.2022.1021828. eCollection 2022. Front Immunol. 2022. PMID: 36569901 Free PMC article.
180 results